CIS Recognized as Third Time Winner of Philadelphia 100(R)

CIS' record-breaking revenue and employee growth among other corporate milestones earns it a Philadelphia 100 Award End Quote

Philadelphia, PA-NJ (1888PressRelease) October 29, 2011 - Compliance Implementation Services (CIS), a leading life sciences consulting firm, announced today that it has again been honored as a winner of the Philadelphia 100®, an annual program conducted by the Entrepreneurs' Forum of Greater Philadelphia, Philadelphia Business Journal and Wharton Small Business Development Center, which tracks the fastest growing, privately held companies in the Greater Philadelphia area.

"CIS continues to strengthen its position as a leader in consultative services through development of new services and solutions that help both our clients and staff stay abreast of ever-changing regulations," said Jim Collins, Chief Financial Officer and Co-founder at CIS. "We have experienced a record 210% revenue and 65% employee growth as a result of the relationships we have made with our clients, which have allowed us to truly become their compliance partner and will enable us to continue growing and innovating to meet their needs for years to come."

CIS has also passed several corporate milestones over the last three years, including:
--133% increase client acquisition
--205% increase in PharmaComplianceXchange™ (PCX) subscribers
--281% increase in Government Programs CalcPartner™ clients

The Philadelphia 100 is a merit-based program that recognizes the fastest growing, privately-held companies in the area. The integrity of the process and the resulting list makes the Philadelphia 100 one of the most sought-after awards in the region. CIS met 2011 Philadelphia 100 criteria by achieving significant profitable growth, sustainable over a three year period with verifiable sales volume and year-over-year revenue increases.

About Compliance Implementation Services (CIS)
Compliance Implementation Services (CIS) is a life sciences consulting firm specializing in compliance strategies for pharmaceutical, biotech, and medical device companies, from global clinical research and development, through manufacturing, U.S. commercial compliance, and government programs. CIS provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to establish a "Culture of Compliance" that is both meaningful and sustainable.

PharmaComplianceXchange™ and CalcPartner™ are trademarks of Compliance Implementation Services, LLC.

###

space

Other Related Press Releases